Protein identification with deep learning: from abc to xyz 

Ngoc Hieu Tran1, Zachariah Levine1, Lei Xin2, Baozhen Shan2, Ming 
Li*, 1 

1 David R. Cheriton School of Computer Science, University of Waterloo, 

Waterloo, Ontario, Canada. 
2 Bioinformatics Solutions Inc., Waterloo, Ontario, Canada. 

* Corresponding author. 

Email: mli@uwaterloo.ca

ABSTRACT 

Proteins are the main workhorses of biological functions in a cell, a 

tissue, or an organism. Identification and quantification of proteins in 

a given sample, e.g. a cell type under normal/disease conditions, are 

fundamental tasks for the understanding of human health and 

disease. In this paper, we present DeepNovo, a deep learning-based 

tool to address the problem of protein identification from tandem 

mass spectrometry data. The idea was first proposed in the context of 

de novo peptide sequencing [1] in which convolutional neural 

networks and recurrent neural networks were applied to predict the 

amino acid sequence of a peptide from its spectrum, a similar task to 

generating a caption from an image. We further develop DeepNovo to 

perform sequence database search, the main technique for peptide 

identification that greatly benefits from numerous existing protein 

databases. We combine two modules de novo sequencing and 

database search into a single deep learning framework for peptide 

identification, and integrate de Bruijn graph assembly technique to 

offer a complete solution to reconstruct protein sequences from 

tandem mass spectrometry data. This paper describes a 

comprehensive protocol of DeepNovo for protein identification, 

including training neural network models, dynamic programming 

search, database querying, estimation of false discovery rate, and de 

Bruijn graph assembly. Training and testing data, model 

implementations, and comprehensive tutorials in form of IPython 

notebooks are available in our GitHub repository 

(https://github.com/nh2tran/DeepNovo). 

 
INTRODUCTION 

While most human cells carry the same genome regardless of their types or 

developmental stages, the proteome, the complete set of proteins in a given cell, 

is much more dynamic due to differential gene expression, alternative splicing, or 

post-translational modifications. Proteomics is the large-scale study of the 

proteome expressed in a given biological sample. Liquid chromatography 

coupled with tandem mass spectrometry (LC-MS/MS) is the current state-of-the-

art technology for protein characterization in proteomics [2-3]. In those 

experiments, proteins are first digested into peptides by different enzymes 

(simply speaking, a long amino acid sequence is cleaved into several short 

subsequences), and the peptides are subsequently analyzed by LC-MS/MS 

instruments. Typical analysis workflows of LC-MS/MS data, e.g. PEAKS, 

OpenMS, include peptide feature detection and quantification from an LC-MS 

map, peptide identification from MS/MS spectra, and protein profiling [4-5].   

In this paper, we focus on the problem of protein identification that includes (i) 

predicting peptide sequences from MS/MS spectra and (ii) assembling those 

peptides back to original protein sequences. The task of peptide identification is 

to predict the amino acid sequence of a peptide given its spectrum and its mass 

(Figure 1). There are 20 standard amino acids and their names are often 

abbreviated by single alphabet letters. Each amino acid has its own molecule 

mass and the peptide mass is the total mass of its amino acids plus its N-

terminal and C-terminal. A spectrum is a collection of (mass, intensity) of ions 

resulted from the fragmentation at the peptide backbone between any two 

adjacent amino acids. For example, consider the peptide 

â€œLHAVTLNNVAEANFFKâ€ and its annotated spectrum in Figure 1. A fragmentation 
between â€œAâ€ and â€œVâ€ at the 3rd and 4th positions results in two fragments â€œLHA-â€ 

and â€œ-VTLNNVAEANFFKâ€ that correspond to two ions b3 and y13, respectively. 

Note that b-ions are indexed from the left to the right of the amino acid sequence 

and y-ions are indexed in the opposite direction. Similarly, a fragmentation 
between â€œVâ€ and â€œTâ€ at the 4th and 5th positions results in two fragments â€œLHAV-â€ 

and â€œ-TLNNVAEANFFKâ€ and two ions b4 and y12. More importantly, the mass 

difference between b3 and b4 as well as the mass difference between y12 and y13 

match the theoretical molecule mass of the amino acid â€œVâ€. Hence, given an 

unannotated spectrum, one could try to iteratively annotate the b-ion and/or y-ion 

series and predict the corresponding amino acid sequence. The total mass of 

predicted amino acids should also match the given peptide mass. 

However, there are multiple computational challenges. While b-ion and y-ion 

series are often observed with strong signals, peptide fragmentation actually may 

produce several types of ions including a, b, c, x, y, z, internal cleavage and 

immonium ions, as well as their sub-types [3]. Different types of ions have their 

own intensity distributions and they always mix up together in both directions with 

respect to the peptide sequence (Figure 1). There are plenty of noise in addition 

to the real signals, while at the same time, there are also real ions missing from 

the spectrum, especially for fragmentation near the two terminals of the peptide 

sequence. Furthermore, we need to take into account measurement errors of 

mass spectrometers for both peptide and its fragment ions. Those challenges 

exponentially explode the search space, making it infeasible to identify the right 

peptide for a spectrum. 

There are two key techniques to tackle the problem of peptide identification. If the 

species information of the biological sample is given, e.g. human, one could 

search the spectrum against a specific protein sequence database of that 

species. In this database search problem, the search space is first reduced to a 

finite set of candidate sequences by filtering based on species and peptide mass. 

Each candidate is then compared to the spectrum based on a match-scoring 

function to select the optimum sequence that best fits the fragment ions in the 

spectrum [6]. If such database information is not available, this becomes a de 

novo sequencing problem, which is much more complicated. Dynamic 

programming algorithms are often required to explore the huge search space to 

find the sequence that maximizes their scoring functions [7]. In general, the two 

techniques, de novo sequencing and database search, share the same idea of 

using some scoring functions to match a spectrum against a peptide, and differ 

by their search strategies. Another useful information for both techniques is the 

digestion enzymes because they often cleave proteins with high specificity. For 

instance, trypsin cuts the peptide bond to the C-terminal side of lysine (â€œKâ€) and 

arginine (â€œRâ€), and hence, most peptides from trypsin digestion have â€œKâ€ or â€œRâ€ at 

the end of their sequence (Figure 1). 

Once the peptides have been identified, it is essential to assemble them back to 

original protein sequences. This problem is similar to genome or transcriptome 

assembly from high-throughput sequencing short reads [8]. While protein 

sequences are much shorter than genome sequences, there are still many 

obstacles including low coverage, sequencing errors and ambiguities, and the 

complexity of protein mixture in the biological sample. Assembly algorithms 

based on overlapping sequences and confidence scores of predicted peptides 

are the keys to solve this problem [9]. 

Our study offers a novel deep learning-based method for peptide identification 

and presents a paradigm shift from algorithm-centric to data-centric approach 

that greatly benefits from the increasing massive amount of data in proteomics. 

In the next section, we describe the details of DeepNovo algorithms for protein 

identification. 

METHODS 

DeepNovo Scoring Function 

The scoring function of DeepNovo was first proposed in [1]. The idea is to 

sequence the peptide by iteratively predicting one amino acid after another and 

the prediction of the next amino acid depends on the output of previous steps 

(see Figure 1 in [1]). Mathematically speaking, we calculate a series of 

conditional probabilities. For example, the score of the sequence â€œPEPTIDEâ€ 

given its spectrum is calculated as in the following equation: 

ğ‘ƒğ‘Ÿğ‘œğ‘(ğ‘ƒğ¸ğ‘ƒğ‘‡ğ¼ğ·ğ¸ | ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š) = ğ‘ƒğ‘Ÿğ‘œğ‘(ğ‘ƒ | ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š)

âˆ—   ğ‘ƒğ‘Ÿğ‘œğ‘(ğ¸ | ğ‘ƒ, ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š)

âˆ—   ğ‘ƒğ‘Ÿğ‘œğ‘(ğ‘ƒ | ğ‘ƒğ¸, ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š)

âˆ—   ğ‘ƒğ‘Ÿğ‘œğ‘(ğ‘‡ | ğ‘ƒğ¸ğ‘ƒ, ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š)

âˆ—   ğ‘ƒğ‘Ÿğ‘œğ‘(ğ¼  | ğ‘ƒğ¸ğ‘ƒğ‘‡, ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š)

âˆ—   ğ‘ƒğ‘Ÿğ‘œğ‘(ğ· | ğ‘ƒğ¸ğ‘ƒğ‘‡ğ¼, ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š)

âˆ—   ğ‘ƒğ‘Ÿğ‘œğ‘(ğ¸ | ğ‘ƒğ¸ğ‘ƒğ‘‡ğ¼ğ·, ğ‘ ğ‘ğ‘’ğ‘ğ‘¡ğ‘Ÿğ‘¢ğ‘š)          Equation (1) 

In the implementation, we actually use the log of probability as the score, and the 

score of a sequence is the sum of its amino acidsâ€™ scores normalized by its 

length. Each conditional probability is computed based on two classification 

models that use the previous output as a prefix to predict the next amino acid. 

The first model uses a convolutional neural network (CNN) [10-11] to learn 

features of the intensity distribution of fragment ions in the spectrum. The second 

model uses a long short-term memory (LSTM) recurrent neural network (RNN) to 

learn sequence patterns of the peptide [12-15]. The final output of those neural 

networks is a probability distribution over 20 classes, i.e. amino acid letters, 

which are used to compute equation (1). 

DeepNovo Database Search 

Knowing the species of the biological sample, we first collect its protein 

sequences from the UniProt database [16]. We use the taxonomy view to select 

all strains of the species and download their Swiss-Prot sequences (since those 

sequences have been carefully annotated and reviewed). Then we perform in 

silico digestion of protein sequences into peptides using the Pyteomics package 

[17], where the cleavage rules are determined by the enzymes used in the 

biological experiments. Other options including maximum number of missed 

cleavages or minimum peptide length are also available. We obtain a list of 

peptide sequences and compute their theoretical mass which altogether serve as 

the database for our search. 

Given each pair of spectrum and experimental peptide mass from the input data, 

we need to query them against the database to identify the best-match peptide 

sequence. The experimental peptide mass is first used to filter the database to a 

set of candidate sequences with approximately same theoretical mass, subject to 

a pre-determined error tolerance. The error tolerance is often measured in part-

per-million (ppm) and hence is proportional to the experimental peptide mass 

rather than an absolute amount. Each candidate sequence is then scored against 

the spectrum using equation (1). It should be noted that while equation (1) shows 

the calculation in the forward direction, we also implement backward direction 

and sum up the score of both directions. The benefits of bi-directional 

sequencing are manifold. First, it reduces the chance of losing information due to 

missing fragment ions near the two terminals. Second, it allows the LSTM model 

to learn sequence patterns around the prediction position rather than from one 

side. Last but not least, using multiple ensembles of the same neural network 

model often increases its accuracy. The highest-scoring candidate is finally 

selected as the predicted peptide sequence. 

DeepNovo De novo Sequencing 

When database information is not available, we have to perform de novo 

sequencing. This is a global optimization problem where we need to find a 

peptide sequence such that its total mass is approximately equal to the 

experimental peptide mass and its matching score against the spectrum is 

maximized. Unlike database search, it is not possible to reduce the search space 

to a finite set of candidate sequences. We apply beam search, a heuristic search 

algorithm that explores a fixed number of top candidate sequences at each 

iteration. Note that the score based on equation (1) is now computed on partial 

sequences during the iterative process, and the final predicted sequence is not 

guaranteed to be the global optimum. The beam search is also accompanied by 

an off-line dynamic programming algorithm to keep comparing the mass of 

predicted sequences and the experimental peptide mass during the iterative 

search. This procedure also helps to filter out those amino acids that do not fit 

the experimental peptide mass. We also apply bi-directional sequencing here, 

but in this case, the forward pass and the backward pass may not necessarily 

produce the same sequence. Overall, de novo sequencing is more heuristic and 

hence less accurate then database search, but this technique can identify novel 

sequences that do not exist in databases. 

DeepNovo Hybrid Solution 

Since we formulate both techniques, database search and de novo sequencing, 

in the same iterative sequencing approach and use the same scoring function, it 

is possible to merge them into a hybrid solution. The idea is that if a peptide is 

novel and does not exist in databases, a de novo sequence is likely to have 

better score than the highest-scoring candidate from database search. This is 

often not the case for existing methods due to inconsistencies in handling those 

two problems (e.g. database search tools often incorporate more features into 

their scoring functions than de novo sequencing tools). 

RESULTS 

Performance Evaluation 

We evaluated the accuracy of DeepNovo de novo sequencing and database 

search on a dataset of Saccharomyces cerevisiae proteome [18]. The data was 

acquired from Thermo Scientific Orbitrap Fusion instrument with the Higher-

energy Collisional Dissociation (HCD) technique. We first used PEAKS DB 

software (version 8.0, [4]) to search against the UniProt database with the yeast 

taxonomy (7,904 protein sequences in total). Other settings include Trypsin 

digestion, maximum two missed cleavages and one non-specific cleavage, 

precursor mass tolerance 20 ppm, fragment ion mass tolerance 0.5 Dalton, fixed 

modification Carbamidomethylation (C), variable modifications Oxidation (M) and 

Deamidation (NQ), and false discovery rate (FDR) of 1%. The peptide sequences 

identified from PEAKS DB search were assigned to the corresponding MS/MS 

spectra and were then used as ground-truth for training and testing the accuracy 

of DeepNovo. There were 347,047 peptide-spectrum matches in total, 90% of 

which were used for training, 5% for validation, and 5% for testing. We calculated 

the total recall as the ratio of the total number of correctly predicted amino acids 

over the total length of target peptide sequences. We also calculated the recall at 

the peptide level, i.e. the fraction of target peptide sequences that were fully 

correctly predicted. Due to the peptide mass constraint, predicted peptide 

sequences tend to have similar lengths to the corresponding targets, so precision 

is often very close to recall and we did not report it here. 

Table 1 show the de novo sequencing and database search results of DeepNovo. 

We also included the de novo sequencing results of PEAKS. It should be noted 

that PEAKS database search results were used as ground-truth, so the 

performance of DeepNovo would not exceed that of PEAKS. A more accurate 

comparison should include several database search tools and use their 

consensus as ground-truth. The preliminary results here show that DeepNovo 

identified 89.8% of peptides from PEAKS database search. We further looked 

into details of the other 10.2% where DeepNovo and PEAKS disagreed. We 

found multiple evidences that DeepNovo predicted high-quality alternative 

peptides to complement PEAKS results. Three examples are shown in Figure 2. 

Interestingly, in the last two examples, DeepNovo predicted the same sequences 

as PEAKS de novo sequencing, while PEAKS database search results were 

different.   

 
 
Table and Figure Legends 

Table 1. The recall of PEAKS and DeepNovo at the amino acid level and the 

peptide level. 

Amino acid recall 

Peptide recall 

PEAKS 
de novo 
57.4% 

25.7% 

DeepNovo 
de novo 
74.3% 

61.7% 

DeepNovo 
database 
89.9% 

89.8% 

Figure 1. An example of peptide, spectrum and annotated fragment ions.   

Figure 2. DeepNovo predicts high-quality alternative peptides to PEAKS results.   

 
 
 
Figure 1 

Figure 2a 

PEAKS  
database  
search 

DeepNovo 
database  
search 

Figure 2b 

PEAKS  
database  
search 

DeepNovo 
database  
search 

Figure 2c 

PEAKS  
database  
search 

DeepNovo 
database  
search 

References 

1.  Tran, N.H., Zhang, X., Xin, L., Shan, B., & Li, M. De novo peptide 

sequencing by deep learning. Proc. Natl. Acad. Sci. U. S. A. 114, 8247â€“
8252 (2017). 

2.  Aebersold, R. & Mann, M. Mass spectrometry-based proteomics. Nature 

422, 198â€“207 (2003).   

3.  Steen, H. & Mann, M. The ABCâ€™s (and XYZâ€™s) of peptide sequencing. Nat. 

Rev. Mol. Cell Biol. 5, 699â€“711 (2004).   

4.  Zhang, J. et al. PEAKS DB: De novo sequencing assisted database 
search for sensitive and accurate peptide identification. Mol. Cell. 
Proteomics 11, M111.010587 (2012). 

5.  Sturm, M. et al. OpenMS - an open-source software framework for mass 

spectrometry. BMC Bioinformatics 9, 163 (2008). 

6.  Eng, J.K., Searle, B.C., Clauser, K.R., & Tabb, D.L. A face in the crowd: 

recognizing peptides through database search. Mol. Cell. Proteomics 10, 
R111.009522 (2011). 

7.  Ma, B. & Johnson, R. De novo sequencing and homology searching. Mol. 

Cell. Proteomics 11, O111.014902 (2012). 

8.  Compeau, P.E., Pevzner, P.A. & Tesler, G. How to apply de Bruijn graphs 

to genome assembly. Nat. Biotechnol. 29, 987-991 (2011).   

9.  Tran, N.H., Rahman, M.Z., He, L., Xin, L., Shan, B., & Li, M. Complete de 
novo assembly of monoclonal antibody sequences. Sci Rep. 6, 31730 
(2016). 

10. LeCun Y., Bengio, Y., & Hinton, G. Deep learning. Nature 521, 436â€“444 

(2015). 

11. Krizhevsky, A., Sutskever, I., & Hinton, G. ImageNet classification with 
deep convolutional neural networks. Advances in Neural Information 
Processing Systems, 1097â€“1105 (2012). 

12. Hochreiter, S. & Schmidhuber, J. Long short-term memory. Neural 

Computation 9, 1735â€“1780 (1997). 

13. Karpathy, A. & Li, F.F. Deep visual-semantic alignments for generating 
image description. IEEE Conference on Computer Vision and Pattern 
Recognition (CVPR), 3128â€“3137 (2015). 

14. Vinyals, O., Toshev, A., Bengio, S. & Erhan, D. Show and tell: a neural 
image caption generator. IEEE Conference on Computer Vision and 
Pattern Recognition (CVPR), 3156â€“3164 (2015). 

15. Mikolov, T., Sutskever, I., Chen, K., Corrado, G. & Dean, J. Distributed 
representations of words and phrases and their compositionality. 
Advances in Neural Information Processing System, 3111â€“3119 (2013). 

16. The UniProt Consortium. UniProt: the universal protein knowledgebase. 

Nucleic Acids Res. 45, D158â€“D169 (2017). 

17. Goloborodko, A.A., Levitsky, L.I., Ivanov, M.V., & Gorshkov, M.V. 

Pyteomics--a Python framework for exploratory data analysis and rapid 
software prototyping in proteomics. J. Am. Soc. Mass Spectrom. 24, 301â€“
304 (2013). 

18. Hebert A.S. et al. The one hour yeast proteome. Mol. Cell. Proteomics 13, 

339â€“347 (2014). 

